Enovis Corp (LTS:0I1B)
$ 49.00706 -0.10705 (-0.22%) Market Cap: 2.73 Bil Enterprise Value: 4.11 Bil PE Ratio: 0 PB Ratio: 0.82 GF Score: 68/100

Colfax Corp at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 11, 2020 / 01:00PM GMT
Release Date Price: $67.97
Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst

© -

And I think we're on. So good morning, everybody. Thanks for joining us. My name is Matt Miksic. I'm medical device analyst here at Crédit Suisse. We're very pleased to have with us this year at our Crédit Suisse Virtual Healthcare Conference, Colfax. We've known for some time in its prior form as DJO and all the businesses under it.

So very pleased to have the team here to give us an update, with Matt Trerotola, President and CEO; Mike Macek, VP of Finance. I'm going to turn it over to Matt to give a 10- or 15-minute introduction and overview, and then we'll get into some Q&A.

So with that, Matt, take it away.

Matthew L. Trerotola
Colfax Corporation - President, CEO & Director

Great. Thanks a lot, Matt. I appreciate it. It's great to be here virtually with everybody. I've got a handful of pages to tee up our company, and then we'll take questions.

I'm going to -- I'm the CEO of Colfax. I'm going to skip

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot